Mimedx (MDXG) Deferred Taxes (2016 - 2026)
Mimedx (MDXG) reported Deferred Taxes of $4.5 million for Q1 2026, up 829.63% on a YoY basis from $487398.4 in Q1 2025, and up 320.92% sequentially from -$2.1 million in Q4 2025.
Mimedx (MDXG) Deferred Taxes (2016 - 2026) Analysis & Trends
Mimedx (MDXG) has 7 years of Deferred Taxes data on file, last reported at $4.5 million in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes rose 829.63% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at -$3.6 million (up 67.84% YoY), and the FY2025 full-year result was -$8.7 million, up 30.16% from the prior year.
- Deferred Taxes rose to $4.5 million in Q1 2026, from -$2.1 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $37.8 million in Q4 2023 to a low of -$5.8 million in Q3 2025.
- A 4-year average of $2.1 million and a median of -$2.0 million in 2024 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes plunged 106.16% in 2024 and surged 829.63% in 2026, its largest moves.
- Tracing MDXG's Deferred Taxes over 4 years: stood at $37.8 million in 2023, then sank by 106.16% to -$2.3 million in 2024, then increased by 11.97% to -$2.1 million in 2025, then soared by 320.92% to $4.5 million in 2026.
- Business Quant data shows MDXG's Deferred Taxes at $4.5 million in Q1 2026, -$2.1 million in Q4 2025, and -$5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Mimedx | 647.22 Mn | 487.45 Mn | 41.62 Mn | 4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.53 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | -5.75 Mn |
| Jun 30, 2025 | -287,000.00 |
| Mar 31, 2025 | -621,000.00 |
| Dec 31, 2024 | -2.33 Mn |
| Sep 30, 2024 | -2.81 Mn |
| Jun 30, 2024 | -5.31 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | 37.80 Mn |
| Dec 31, 2018 | 23.98 Mn |
| Sep 30, 2018 | 5.84 Mn |
| Jun 30, 2018 | -3.01 Mn |
| Mar 31, 2018 | -1.27 Mn |
| Dec 31, 2017 | -18.11 Mn |
| Sep 30, 2017 | -7.53 Mn |
| Jun 30, 2017 | -614,000.00 |
| Mar 31, 2017 | -416,000.00 |
| Dec 31, 2016 | -5.54 Mn |
| Sep 30, 2016 | -93,000.00 |